Pages that link to "Q28254168"
Jump to navigation
Jump to search
The following pages link to A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults (Q28254168):
Displaying 50 items.
- The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003 (Q21257242) (← links)
- Herpes zoster in Germany: quantifying the burden of disease (Q21261833) (← links)
- Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine (Q21562177) (← links)
- Vaccines for preventing herpes zoster in older adults (Q24186050) (← links)
- Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults (Q24193819) (← links)
- Vaccines for preventing herpes zoster in older adults (Q24198256) (← links)
- Antiviral treatment for preventing postherpetic neuralgia (Q24200526) (← links)
- Vaccination for preventing postherpetic neuralgia (Q24235822) (← links)
- Vaccines for preventing herpes zoster in older adults (Q24235910) (← links)
- Antiviral treatment for preventing postherpetic neuralgia (Q24241326) (← links)
- Vaccination for preventing postherpetic neuralgia (Q24241959) (← links)
- Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults (Q24242809) (← links)
- Antiviral treatment for preventing postherpetic neuralgia (Q24243751) (← links)
- Vaccinology in the third millennium: scientific and social challenges (Q24261399) (← links)
- Neuropathic pain: a practical guide for the clinician (Q24553796) (← links)
- Recommendations for the pharmacological management of neuropathic pain: an overview and literature update (Q24616897) (← links)
- Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials (Q24622122) (← links)
- Update on herpes zoster vaccination: a family practitioner's guide (Q24635096) (← links)
- Microbiology laboratory and the management of mother-child varicella-zoster virus infection (Q26738745) (← links)
- Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review (Q26748712) (← links)
- Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal (Q26749096) (← links)
- Varicella Zoster Virus in the Nervous System (Q26766220) (← links)
- Herpes Zoster: the rationale for the introduction of vaccination in Italy (Q26770662) (← links)
- Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease (Q26777330) (← links)
- Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions (Q26777442) (← links)
- Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective (Q26781940) (← links)
- Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment (Q26801569) (← links)
- Adult vaccination (Q26824961) (← links)
- Vaccination against herpes zoster in developed countries: state of the evidence (Q26862748) (← links)
- Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data (Q26863614) (← links)
- Evaluation of efficacy and effectiveness of live attenuated zoster vaccine (Q26866473) (← links)
- Reducing the burden of Herpes Zoster in Italy (Q26998625) (← links)
- Animal models of varicella zoster virus infection (Q27011703) (← links)
- Synthetic DNA vaccine strategies against persistent viral infections (Q27016078) (← links)
- Vaccination of special populations: Protecting the vulnerable (Q28066325) (← links)
- Herpes zoster and postherpetic neuralgia in older adults (Q28111717) (← links)
- Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults (Q28111945) (← links)
- The neurotropic herpes viruses: herpes simplex and varicella-zoster (Q28111976) (← links)
- Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program (Q28248854) (← links)
- Vaccination against Herpes Zoster and Postherpetic Neuralgia (Q28276808) (← links)
- Varicella zoster vaccines and their implications for development of HSV vaccines (Q28280820) (← links)
- Recommendations for the Management of Herpes Zoster (Q28315869) (← links)
- Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective (Q28388806) (← links)
- Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia (Q28468596) (← links)
- Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor (Q28474768) (← links)
- Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study (Q28547474) (← links)
- Quantification of risk factors for herpes zoster: population based case-control study (Q28657403) (← links)
- Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification (Q28757353) (← links)
- Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults (Q30251448) (← links)
- HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development (Q30355260) (← links)